AUTHOR=Souza José Diogo S. , Fassoni-Ribeiro Maíra , Batista Rayssa Miranda , Ushirohira Juliana Mayumi , Zuardi Antonio W. , Guimarães Francisco S. , Campos Alline C. , Osório Flávia de Lima , Elias Daniel , Souza Cacilda S. , Fassoni AndRea A. , Hallak Jaime E. C. , Crippa José Alexandre S. 

TITLE=Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations

JOURNAL=Frontiers in Pharmacology

VOLUME=13

YEAR=2022

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.881617

DOI=10.3389/fphar.2022.881617

ISSN=1663-9812

ABSTRACT=<p>Cannabidiol (CBD) is a non-psychotomimetic constituent of the <italic>Cannabis</italic> plant, with potential therapeutic properties for many physical and neuropsychiatric conditions. Isolated CBD has been suggested to have favorable safety and tolerability. Although CBD-related rash is described, few case reports are well documented in the literature, and usually, CBD was used concomitantly with other medications. Thus, we report four women who presented a skin rash after ongoing CBD use. Other causes of these skin rashes were ruled out after conducting an extensive viral and serological detection panel, and three patients had their lesions biopsied. Two patients were re-exposed to the vehicle (MCT) without developing a new skin rash. Therefore, clinicians must be aware of this potential adverse effect of CBD use.</p>